Menopausal hormone therapy and ovarian cancer risk

被引：0
|
作者：
Lacey, James V., Jr.
Brinton, Louise A.
Leitzmann, Michael F.
Mouw, Traci
Hartge, Patricia
Hollenbeck, Albert R.
Schatzkin, Arthur
机构：
[1] NCI, DCEG, Rockville, MD USA
[2] AARP, Washington, DC USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Menopausal hormone therapy and risk of epithelial ovarian cancer
    Rossing, Mary Anne
    Cushing-Haugen, Kara L.
    Wicklund, Kristine G.
    Doherty, Jennifer A.
    Weiss, Noel S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (12) : 2548 - 2556
  • [2] Menopausal hormone replacement therapy and risk of ovarian cancer
    Lacey, JV
    Mink, PJ
    Lubin, JH
    Sherman, ME
    Troisi, R
    Hartge, P
    Schatzkin, A
    Schairer, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 334 - 341
  • [3] Menopausal hormone therapy—ovarian cancer risk revisited
    Susan R. Davis
    Rodney Baber
    Nature Reviews Endocrinology, 2015, 11 : 322 - 323
  • [4] Menopausal hormone therapy and ovarian cancer: Putting risk into perspective
    Perez-Lopez, Faustino R.
    Rees, Margaret
    MATURITAS, 2015, 81 (01) : 3 - 4
  • [5] Menopausal hormone therapy-ovarian cancer risk revisited
    Davis, Susan R.
    Baber, Rodney
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (06) : 322 - 323
  • [6] Menopausal hormone use: risk of ovarian cancer
    Reactions Weekly, 2015, 1540 (1) : 11 - 11
  • [7] Menopausal hormone therapy and cancer risk
    Ortmann O.
    Schüler-Toprak S.
    Der Gynäkologe, 2017, 50 (8): : 586 - 598
  • [8] Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition
    Konstantinos K. Tsilidis
    Naomi E. Allen
    Timothy J. Key
    Laure Dossus
    Rudolf Kaaks
    Kjersti Bakken
    Eiliv Lund
    Agnès Fournier
    Christina C. Dahm
    Kim Overvad
    Louise Hansen
    Anne Tjønneland
    Sabina Rinaldi
    Isabelle Romieu
    Marie-Christine Boutron-Ruault
    Francoise Clavel-Chapelon
    Annekatrin Lukanova
    Heiner Boeing
    Madlen Schütze
    Vassiliki Benetou
    Domenico Palli
    Franco Berrino
    Rocco Galasso
    Rosario Tumino
    Carlotta Sacerdote
    H. Bas Bueno-de-Mesquita
    Fränzel J. B. van Duijnhoven
    Marieke G. M. Braem
    N. Charlotte Onland-Moret
    Inger T. Gram
    Laudina Rodríguez
    Eric J. Duell
    María-José Sánchez
    José María Huerta
    Eva Ardanaz
    Pilar Amiano
    Kay-Tee Khaw
    Nick Wareham
    Elio Riboli
    Cancer Causes & Control, 2011, 22 : 1075 - 1084
  • [9] Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition
    Tsilidis, Konstantinos K.
    Allen, Naomi E.
    Key, Timothy J.
    Dossus, Laure
    Kaaks, Rudolf
    Bakken, Kjersti
    Lund, Eiliv
    Fournier, Agnes
    Dahm, Christina C.
    Overvad, Kim
    Hansen, Louise
    Tjonneland, Anne
    Rinaldi, Sabina
    Romieu, Isabelle
    Boutron-Ruault, Marie-Christine
    Clavel-Chapelon, Francoise
    Lukanova, Annekatrin
    Boeing, Heiner
    Schuetze, Madlen
    Benetou, Vassiliki
    Palli, Domenico
    Berrino, Franco
    Galasso, Rocco
    Tumino, Rosario
    Sacerdote, Carlotta
    Bueno-de-Mesquita, H. Bas
    van Duijnhoven, Franzel J. B.
    Braem, Marieke G. M.
    Onland-Moret, N. Charlotte
    Gram, Inger T.
    Rodriguez, Laudina
    Duell, Eric J.
    Sanchez, Maria-Jos
    Huerta, Jose Maria
    Ardanaz, Eva
    Amiano, Pilar
    Khaw, Kay-Tee
    Wareham, Nick
    Riboli, Elio
    CANCER CAUSES & CONTROL, 2011, 22 (08) : 1075 - 1084
  • [10] A Commentary on a recent update of the ovarian cancer risk attributable to menopausal hormone therapy
    Gompel, A.
    Burger, H.
    CLIMACTERIC, 2015, 18 (03) : 376 - 378
12345